Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor

Am J Obstet Gynecol. 2004 Jun;190(6):1582-7; discussion 1587-9. doi: 10.1016/j.ajog.2004.03.059.

Abstract

Objective: The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth.

Study design: In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin.

Results: These women comprised 4 groups: group A (n=23 women; +bacterial vaginosis/+fetal fibronectin); group B (n=31 women; -bacterial vaginosis/+fetal fibronectin); group C (n=47 women; +bacterial vaginosis/-fetal fibronectin); and group D (n=84 women; -bacterial vaginosis/-fetal fibronectin). The time interval from gestational age at testing until delivery was significantly shorter for groups A and B versus groups C and D (P < or =.05 and P <.001, respectively). Similarly, delivery at <32 weeks of gestation was increased in group B (26%) compared with groups A (9%), C (2%), and D (5%; P <.009; odds ratio, 165.90; 95% CI, 30.02, 916.08).

Conclusion: Women who are symptomatic for preterm labor should be considered for fetal fibronectin and bacterial vaginosis testing.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Cohort Studies
  • Female
  • Fibronectins*
  • Gestational Age
  • Glycoproteins / analysis
  • Glycoproteins / metabolism*
  • Humans
  • Incidence
  • Infant, Newborn
  • Infant, Premature
  • Obstetric Labor, Premature / epidemiology*
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Outcome*
  • Probability
  • Prospective Studies
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Statistics, Nonparametric
  • Vaginosis, Bacterial / diagnosis
  • Vaginosis, Bacterial / epidemiology*

Substances

  • Biomarkers
  • FFN protein, human
  • Fibronectins
  • Glycoproteins